Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease.
about
Targeting folate receptor alpha for cancer treatmentEffective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression levelPolymersome-based drug-delivery strategies for cancer therapeuticsOne-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy.Fluorescent, Plasmonic, and Radiotherapeutic Properties of the 177Lu-Dendrimer-AuNP-Folate-Bombesin Nanoprobe Located Inside Cancer CellsFolate receptor-α (FOLR1) expression and function in triple negative tumorsFolate receptor α expression and significance in endometrioid endometrium carcinoma and endometrial hyperplasia.Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha.Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advancesTargeted Proteomics Enables Simultaneous Quantification of Folate Receptor Isoforms and Potential Isoform-based Diagnosis in Breast Cancer.Expression of high affinity folate receptor in breast cancer brain metastasis.Folate Receptor-Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast CancerSerum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4.Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations.Folic acid induces cell type-specific changes in the transcriptome of breast cancer cell lines: a proof-of-concept study.Concordance of folate receptor-α expression between biopsy, primary tumor and metastasis in breast cancer and lung cancer patients.Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17GPI transamidase and GPI anchored proteins: oncogenes and biomarkers for cancer.Development of a New Folate-Derived Ga-68-Based PET Imaging Agent.Small Molecules for Active Targeting in Cancer.Utility of folate receptor alpha immunohistochemistry in cytology specimens of metastatic breast carcinoma, metastatic serous carcinoma of Müllerian origin, and primary lung adenocarcinoma.In-vivo monitoring of anti-folate therapy in arthritic rats using [18F]fluoro-PEG-folate and positron emission tomography.Folate-PEG Conjugates of a Far-Red Light-Activatable Paclitaxel Prodrug to Improve Selectivity toward Folate Receptor-Positive Cancer Cells.LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer.Folate receptor-targeted aminoglycoside-derived polymers for transgene expression in cancer cells.Cytotoxic Conjugates of Fibroblast Growth Factor 2 (FGF2) with Monomethyl Auristatin E for Effective Killing of Cells Expressing FGF Receptors.Anti-Folate Receptor Alpha-Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer177Lu-Dendrimer Conjugated to Folate and Bombesin with Gold Nanoparticles in the Dendritic Cavity: A Potential Theranostic Radiopharmaceutical
P2860
Q26744215-B9246787-F07A-44B8-A873-29D8577683A0Q27300701-C35B080C-33A9-426D-A314-C4298E6EB71CQ28083454-2F547A85-315D-4976-88B6-145E9F48C081Q33618935-EB6C408F-6307-49B2-A2A2-3FF3070D3261Q33793282-421C66A9-132E-490A-B0C0-CCA68F0E3641Q35225064-3E45AA12-7026-45DD-B8C8-7CD404BEB90AQ35854305-CCB617AA-B8CF-4F76-9348-177B5046F0BBQ35915267-0D7C70B6-AAB3-470D-965C-F5D7F8E23171Q36157045-14F8B45B-ADF2-4A30-A80C-B832284B9002Q36287593-EC1695A8-53B9-4BEE-9F1E-5226273DEBE2Q36557588-553F4915-08E9-4504-B734-BB4CDF46ECC9Q36563827-9368A2A7-337F-4F4F-BC44-42194F07C6BCQ36808757-DFED0EB8-E262-476B-81E4-5A46A9B0913EQ36820304-EC09C51F-9219-42B7-8869-A2EFF3746C50Q36964902-D1EDDCE3-BBC1-485E-8833-89180A134124Q37109499-74DEA95D-8447-4BBE-BBE8-1C6629EB77C2Q37362630-B3394296-DA48-4DE8-B33D-6479AC107A2FQ38131553-B96F0B2C-1676-4462-88C7-1621E3FD9811Q38716580-F25EEF8A-9B5B-4045-8DC4-F348EAEE8320Q38780383-C041C34B-A9FA-4357-85F3-850357C7EFF5Q39997968-C8C22F18-076C-4D8A-A848-11D24D90A4A2Q41808297-AD9A589A-4999-4788-8C6E-219343AA5848Q44583167-65F33AEE-638F-4622-BA6D-A2A34DB348F0Q47987587-E842C8E8-A8EC-4BB3-B32E-D28575B773B2Q54942026-C53343CB-6B91-42AB-A408-E2E3B76DA457Q55669491-9D041C7D-ECC9-4136-9294-2BB2FA5E3CFAQ57462222-603EB906-E454-420D-B78A-F71F8639A901Q59127979-07E6521E-B2F9-43D1-8828-29AB8EA40D74
P2860
Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 September 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Folate receptor alpha (FRA) ex ...... with triple negative disease.
@en
Folate receptor alpha
@nl
type
label
Folate receptor alpha (FRA) ex ...... with triple negative disease.
@en
Folate receptor alpha
@nl
prefLabel
Folate receptor alpha (FRA) ex ...... with triple negative disease.
@en
Folate receptor alpha
@nl
P2093
P2860
P356
P1433
P1476
Folate receptor alpha (FRA) ex ...... with triple negative disease.
@en
P2093
Daniel J O'Shannessy
Elizabeth B Somers
Julia Maltzman
Robert Smale
Yao-Shi Fu
P2860
P2888
P356
10.1186/2193-1801-1-22
P577
2012-09-28T00:00:00Z
P5875
P6179
1038903384